Publications

5674 Results

Exploratory methods in survival analysis.

Authors
J Crowley;M LeBlanc;R Gentleman;S Salmon
Journal / Conference
IMS Lecture Notes - Monograph Series 27:55-77
Year
1995
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30

A study of the mechanism of IFN alfa-2b in high-risk melanoma in the ECOG/Intergroup trial E1690.

Authors
JM Kirkwood;J Sosman;M Ernstoff;M Ross;C Gerstner;J Bryant;T Whiteside;C Johnson
Journal / Conference
American Association for Cancer Research 36(#3815):641
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9325 (EST-2690)

Recent American multicenter trials for patients with metastatic prostate cancer.

Authors
E DeAntoni;ED Crawford
Journal / Conference
Urologe (A) 34:382-388
Year
1995
Research Committee(s)
Genitourinary

CAF vs 16 week multidrug regimen as adjuvant therapy for receptor-negative, node-positive breast cancer: An Intergroup study.

Authors
J Fetting;R Gray;M Abeloff;B Fowble;T Smith;S Vail;G Durrani;L Eudey;J Henney;K Margolin;M Citron;C Osborn;C Henderson
Journal / Conference
American Society of Clinical Oncology 14(#83):96
Year
1995
Research Committee(s)
Breast
Study Number(s)
SWOG-8931 (INT-0108) (EST-3189)

Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials.

Authors
M Clarke;R Collins;J Godwin;R Gray;R Peto
Journal / Conference
New England Journal of Medicine 333(22):1444-1455
Year
1995
Research Committee(s)
Breast

Phase III randomized study of all-trans retinoic acid (ATRA) vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia (APL).

Authors
MS Tallman;J Andersen;CA Schiffer;FR Appelbaum;JE Feusner;WG Woods;A Ogden;H Weinstein;L Shepherd;JM Rowe;PH Wiernik
Journal / Conference
Blood 86(10)(Suppl.1)(#488):125a
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group.

Authors
EL Sievers;FO Smith;WG Woods;JW Lee;WA Bleyer;CL Willman;ID Bernstein
Journal / Conference
Leukemia 9:2042-2048
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600

NCAM-associated tumors: Are they a discrete group of disorders?

Authors
TP Miller;TM Grogan
Journal / Conference
Lymphoma Conference Program and Summaries-San Antonio Texas
Year
1995
Research Committee(s)
Lymphoma

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer.

Authors
WT Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;WJ Curran;RW Byhardt;AT Turrisi;AR Dar;J D Cox
Journal / Conference
Journal of the National Cancer Institute 87(3):198-205
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

RTOG 8808 ECOG 4588, Preliminary analysis of a phase III trial in regionally advanced unresectable non-small cell lung cancer with minimum three year follow-up.

Authors
WT Sause;C Scott;S Taylor;D Johnson;R Livingston;R Komaki;JD Cox;B Emami;WJ Curran;RW Byhardt;AR Dar;AT Turrisi
Journal / Conference
Int.l Journal of Radation Oncology Biology Phyics 32Suppl:195(#109)
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)